Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftobiprole PK in Patients With CSF Device
NCT03317093Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Mar 2018
- Primary completion
- Oct 2019
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of ceftobiprole medocaril in bacterial meningitis, ventriculitis, sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Started Mar 2018; status: completed.
02
Drugs
ceftobiprole medocaril
03
Conditions
bacterial meningitisventriculitis
Beyond the preview
Go deeper on NCT03317093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03317093.